Covidien Acquires Reverse Medical Corporation

August 22, 2014

Covidien announced Friday it has acquired privately held vascular disease devicemaker Reverse Medical Corporation for an undisclosed sum.

The deal will bolster Covidien’s portfolio of vascular technologies, enabling the company to better compete in the worldwide vascular embolization market, which is experiencing double digit growth, says Brett Wall, president of the company’s Neurovascular unit.

Irvine, Calif.-based Reverse Medical produces the MVP Micro Vascular Plug System and the UNO Neurovascular Embolization System. Both are self-expanding vessel occlusion devices, which close blood vessels for embolization. The technology is required in a number of clinical applications to quickly, safely and effectively stop blood flow.

Reverse Medical also makes the ReVerse Mircocatheter for device delivery and an aneurysm bridging device, the Barrel Vascular Reconstruction Device. All of the company’s devices are CE-marked, and the MVP Micro has 510(k) clearance in the U.S. — Kellen Owings

Subscribe to Devices & Diagnostics Letter for complete coverage of the medical devices industry. Click here for more information.